FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384405424> ?p ?o ?g. }

• W4384405424 abstract "Abstract Background Both elevated inflammation and atherogenic dyslipidemia are prominent in young-onset diabetes and are increasingly identified as biologically intertwined processes that contribute to diabetogenesis. We aimed to investigate the age-specific risks of type 2 diabetes (T2D) upon concomitant chronic inflammation and atherogenic dyslipidemia. Methods Age-stratified Cox regression analysis of the risk of incident diabetes upon co-exposure to time-averaged cumulative high-sensitivity C-reactive protein (CumCRP) and atherogenic index of plasma (CumAIP) among 42,925 nondiabetic participants from a real-world, prospective cohort (Kailuan Study). Results During a median 6.41 years of follow-up, 3987 T2D developed. Isolated CumAIP and CumCRP were significantly associated with incident T2D in the entire cohort and across all age subgroups. Both CumAIP and CumCRP were jointly associated with an increased risk of diabetes ( P -interaction = 0.0126). Compared to CumAIP < -0.0699 and CumCRP < 1 mg/L, co-exposure to CumAIP ≥ − 0.0699 and CumCRP ≥ 3 mg/L had a significant hazard ratio (HR) [2.55 (2.23–2.92)] after adjusting for socio-demographic, life-style factors, family history of diabetes, blood pressure, renal function and medication use. The co-exposure-associated risks varied greatly by age distribution ( P -interaction = 0.0193): < 40 years, 6.26 (3.47–11.28); 40–49 years, 2.26 (1.77–2.89); 50–59 years, 2.51 (2.00–3.16); 60–69 years, 2.48 (1.86–3.30); ≥ 70 years, 2.10 (1.29–3.40). In young adults (< 45 years), both exposures had a significant supra-additive effect on diabetogenesis (relative excess risk due to interaction: 0.80, 95% CI 0.10–1.50). Conclusions These findings highlight the need for age-specific combined assessment and management of chronic inflammation and dyslipidemia in primary prevention against T2D, particularly for young adults. The clinical benefit derived from dual-target intervention against dyslipidemia and inflammation will exceed the sum of each part alone in young adults." @default.
• W4384405424 created "2023-07-16" @default.
• W4384405424 creator A5005171412 @default.
• W4384405424 creator A5014659532 @default.
• W4384405424 creator A5019426685 @default.
• W4384405424 creator A5028350370 @default.
• W4384405424 creator A5032842399 @default.
• W4384405424 creator A5032867006 @default.
• W4384405424 creator A5038035670 @default.
• W4384405424 creator A5046597133 @default.
• W4384405424 creator A5048740840 @default.
• W4384405424 creator A5058150411 @default.
• W4384405424 creator A5059763907 @default.
• W4384405424 creator A5065942078 @default.
• W4384405424 creator A5066002407 @default.
• W4384405424 creator A5067271913 @default.
• W4384405424 creator A5074025151 @default.
• W4384405424 creator A5074338793 @default.
• W4384405424 date "2023-07-15" @default.
• W4384405424 modified "2023-10-17" @default.
• W4384405424 title "Supra-additive effect of chronic inflammation and atherogenic dyslipidemia on developing type 2 diabetes among young adults: a prospective cohort study" @default.
• W4384405424 cites W1545960046 @default.
• W4384405424 cites W1969606544 @default.
• W4384405424 cites W1991844313 @default.
• W4384405424 cites W1993803682 @default.
• W4384405424 cites W2019108601 @default.
• W4384405424 cites W2020659754 @default.
• W4384405424 cites W2029685045 @default.
• W4384405424 cites W2030522545 @default.
• W4384405424 cites W2035576567 @default.
• W4384405424 cites W2050756945 @default.
• W4384405424 cites W2062756785 @default.
• W4384405424 cites W2079773881 @default.
• W4384405424 cites W2080549540 @default.
• W4384405424 cites W2080755877 @default.
• W4384405424 cites W2082402714 @default.
• W4384405424 cites W2104005551 @default.
• W4384405424 cites W2152934881 @default.
• W4384405424 cites W2153399820 @default.
• W4384405424 cites W2155965977 @default.
• W4384405424 cites W2264523161 @default.
• W4384405424 cites W2342166197 @default.
• W4384405424 cites W2411445025 @default.
• W4384405424 cites W2509820133 @default.
• W4384405424 cites W2567264284 @default.
• W4384405424 cites W2586320696 @default.
• W4384405424 cites W2607031541 @default.
• W4384405424 cites W2622955276 @default.
• W4384405424 cites W2761065987 @default.
• W4384405424 cites W2768267412 @default.
• W4384405424 cites W2884081989 @default.
• W4384405424 cites W2900975908 @default.
• W4384405424 cites W2923237341 @default.
• W4384405424 cites W2946946340 @default.
• W4384405424 cites W2972869264 @default.
• W4384405424 cites W2993908729 @default.
• W4384405424 cites W3012481772 @default.
• W4384405424 cites W3020528808 @default.
• W4384405424 cites W3039034380 @default.
• W4384405424 cites W3088444866 @default.
• W4384405424 cites W3094776117 @default.
• W4384405424 cites W3095570107 @default.
• W4384405424 cites W3101822035 @default.
• W4384405424 cites W3142840603 @default.
• W4384405424 cites W3153959337 @default.
• W4384405424 cites W3159242155 @default.
• W4384405424 cites W3160407865 @default.
• W4384405424 cites W3161593331 @default.
• W4384405424 cites W3163017291 @default.
• W4384405424 cites W320726453 @default.
• W4384405424 cites W4205735270 @default.
• W4384405424 cites W4213157453 @default.
• W4384405424 cites W4220665597 @default.
• W4384405424 cites W4225939851 @default.
• W4384405424 cites W4287838045 @default.
• W4384405424 cites W4311263986 @default.
• W4384405424 cites W4318755434 @default.
• W4384405424 cites W71247350 @default.
• W4384405424 doi "https://doi.org/10.1186/s12933-023-01878-5" @default.
• W4384405424 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37454077" @default.
• W4384405424 hasPublicationYear "2023" @default.
• W4384405424 type Work @default.
• W4384405424 citedByCount "0" @default.
• W4384405424 crossrefType "journal-article" @default.
• W4384405424 hasAuthorship W4384405424A5005171412 @default.
• W4384405424 hasAuthorship W4384405424A5014659532 @default.
• W4384405424 hasAuthorship W4384405424A5019426685 @default.
• W4384405424 hasAuthorship W4384405424A5028350370 @default.
• W4384405424 hasAuthorship W4384405424A5032842399 @default.
• W4384405424 hasAuthorship W4384405424A5032867006 @default.
• W4384405424 hasAuthorship W4384405424A5038035670 @default.
• W4384405424 hasAuthorship W4384405424A5046597133 @default.
• W4384405424 hasAuthorship W4384405424A5048740840 @default.
• W4384405424 hasAuthorship W4384405424A5058150411 @default.
• W4384405424 hasAuthorship W4384405424A5059763907 @default.
• W4384405424 hasAuthorship W4384405424A5065942078 @default.
• W4384405424 hasAuthorship W4384405424A5066002407 @default.
• W4384405424 hasAuthorship W4384405424A5067271913 @default.
• W4384405424 hasAuthorship W4384405424A5074025151 @default.
• W4384405424 hasAuthorship W4384405424A5074338793 @default.

• next